Business UpdateJun 9, 2026, 06:01 AM
Enveric Biosciences Releases Q2 2026 Investor Presentation
AI Summary
Enveric Biosciences, Inc. announced the release of its Investor Presentation on its website around June 8, 2026. These materials will be utilized by management in future presentations to current and potential investors, analysts, and other stakeholders. The Investor Presentation Q2 2026 is included as Exhibit 99.1 to the Form 8-K.
Key Highlights
- Enveric Biosciences to release Investor Presentation on its website around June 8, 2026.
- The presentation will be used for future engagements with investors, analysts, lenders, and business partners.
- A copy of the Investor Presentation Q2 2026 is furnished as Exhibit 99.1 to the report.
- The Investor Presentation is also accessible via the company's investor relations website.
- The information is furnished under Regulation FD and not deemed 'filed' for Section 18 purposes.
Price Impact
More from ENVB